FreeTCCL Archive Phase III Trial: Panobinostat Increases PFS by Four Months October 01, 2014Vol.37 No.09
FreeTCCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials October 01, 2014Vol.37 No.09
FreeTCCL Archive Pancreatic Neuroendocrine Tumors Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial October 01, 2014Vol.37 No.09
FreeTCCL Archive Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months October 01, 2014Vol.37 No.09
FreeTCCL Archive FDA Approves Avastin Combination For Late-Stage Cervical Cancer August 30, 2014Vol.37 No.08
FreeTCCL Archive Study: Nine Years After Diagnosis 9.3% of Survivors Still Smoke August 30, 2014Vol.37 No.08
